Recent Updates
Recently added Catalysts
BLTE Positive Sentiment Score: 70/100

Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results

Wednesday, May 7, 2025 1 min read
Key Takeaway: Belite Bio, a clinical-stage biopharmaceutical company, will host a webcast on May 14, 2025, to discuss its financial results for the first quarter of 2025, ending March 31. This event reflects the company's commitment to keeping its investors informed about its financial performance and business developments. Participants can access the webcast via a specific link, which will remain available for 90 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Belite Bio is holding a webcast to discuss financial results, indicating transparency and engagement with investors.
  • The upcoming discussion focuses on a quarter that may show progress in their drug development efforts for retinal diseases.

Full Press Release Details

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Wednesday, May 14, 2025, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update for the first quarter ended March 31, 2025.
Date: Wednesday, May 14, 2025
Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
Webcast Link: https://events.q4inc.com/attendee/137642555
Webcast Link Instructions
You can join the live webcast by visiting the link above or the “Presentations & Events” section of the Company’s Investor Relations website at https://investors.belitebio.com/presentations-events/events. A replay will be available for approximately 90 days after the event.
Media and Investor Relations Contact:
belite@argotpartners.com

Frequently Asked Questions

When is the Belite Bio webcast scheduled?

The Belite Bio webcast is on May 14, 2025, at 4:30 p.m. Eastern Time.

How can I access the Belite Bio webcast?

You can access the webcast via the provided link or on their Investor Relations site.

Will there be a replay of the Belite Bio webcast?

Yes, a replay will be available for about 90 days after the event.

What is Belite Bio focused on developing?

Belite Bio develops novel therapeutics for degenerative retinal diseases.

Who should I contact for media inquiries?

For media inquiries, contact belite@argotpartners.com.

Tags: BLTE Viatris Investor Conferences Healthcare Belite Bio financial results webcast retinal diseases biopharmaceutical
Last updated: May 7, 2025